Search bioRxiv⌕ Search

Biology subjects

Nunzi, E.

Publications and source records attributed to Nunzi, E..

2 recordsLinked to original sources

Geometric averaging provides normalization-invariant feature ranking in compositional sequencing data

In compositional next-generation sequencing (NGS) analyses (including microbiome studies, RNA-seq and metagenomics) the arithmetic mean (AM) of relative proportions is the default operator for summarizing feature abundances. We show that this default produces unstable rankings in real compositional data. Across 102 prevalent genera in the dietswap dataset (n=38 baseline samples), 23 genera (22.5%), including members of Bacteroides, Eubacterium and Bilophila, yielded opposite group-level conclusions under AM and the geometric mean (GM). This pattern reflects two formal properties of compositional aggregation. First, AM-based rankings change with the within-sample normalization domain, whereas GM-based rankings are invariant under the multiplicative structure of compositional data. Second, the centered log-ratio (CLR) transformation absorbs geometric averaging into the data representation, so that arithmetic averaging on CLR-space recovers the GM ranking exactly. Both properties were verified numerically on the dietswap dataset, where the Spearman correlation between GM- and CLR-based rankings was 1.000 in both groups. The operator-choice problem propagates to between-group differential inference: under AM, log2 fold-changes vary across normalizations and the relative ranking of features by effect size is not preserved; under GM and CLR, the ranking is preserved. We recommend GM-based summaries for feature ranking and CLR-transformed abundances for cross-sample comparisons. This change requires no new computational tools and is fully compatible with existing differential-abundance pipelines, but eliminates an under-recognized source of irreproducibility in biomarker discovery across microbiome studies, transcriptomics, metagenomics, and mass-spectrometry-based metabolomics, in all settings where features are quantified relative to a sample total. IMPORTANCEStudies of the gut microbiome routinely identify which bacterial groups are more or less abundant in patients versus healthy controls, in different diets, or before and after a treatment. The same kind of comparison underlies sequencing-based analyses across biology, from gene expression to metagenomics. To do this, researchers must average the abundance of each measured entity across many samples, and the standard choice is the simple arithmetic average. We show that this choice can be misleading for any data where each measurement is expressed relative to a sample total, as is typical of sequencing-based assays, and that in real data it can flip the answer to which group is more enriched. Analyzing a published dietary intervention study, we found that one in five gut bacteria (including Bacteroides and Eubacterium) gave opposite results depending on which average was used. Switching to the geometric average resolves this inconsistency and makes biomarker discovery more reproducible. This change is immediate to implement (it does not require new software or specialized training) and applies not only to microbiome studies, but to any biological measurement where what is detected, whether a gene transcript, a microbial taxon, or a metabolite, is quantified relative to a sample total: gene-expression analysis, metagenomics, and metabolomics among others.

bioinformatics↗

Reduction of fungal dysbiosis is involved in the attenuation of Dextran Sodium Sulfate-Induced Mouse Colitis Mediated by GILZ protein and yeast extract compound

Inflammatory bowel diseases (IBD), such as Crohns disease and ulcerative colitis, have a complex and multifactorial pathogenesis that remains not fully elucidated. Recent research suggests that intestinal fungal dysbiosis may contribute to the development and persistence of IBD. In this study, we explored, for the first time, the effects of the glucocorticoid-induced leucine zipper (GILZ) protein, known to have protective effects on the gut mucosa in preclinical IBD models, in combination with a yeast extract, which supports the growth of beneficial microorganisms, in a mouse model of ulcerative colitis. The combined treatment produced significant protection against severe disease outcomes in the mice, including the restoration of intestinal barrier integrity and the reduction of pro-inflammatory cytokines. Specifically, GILZ primarily acted on the gut permeability, while the yeast extract mainly reduced pro-inflammatory cytokines. Notably, both treatments were effective in restoring the intestinal burden of clinically important Candida and former Candida species. Analysis of the intestinal fungal communities revealed that both treatments were able to reduce colitis-associated fungal dysbiosis, promoting a fungal composition similar to that of healthy mice. This effect was mainly the result of a decreased abundance of the Meyerozima genus, which was dominant in the colitic mice. Thus, combined treatment regimens with the GILZ protein and yeast extract could represent a new strategy for the treatment of inflammatory bowel diseases, by targeting multiple mechanisms at the basis of IBD, including the fungal dysbiosis. IMPORTANCEInflammatory bowel diseases (IBD), including Crohns disease and ulcerative colitis, are characterized by chronic inflammation and have a complex, multifactorial pathogenesis that is not yet fully understood. Currently, no established therapeutic strategy can consistently manage IBD effectively. Recent research indicates that intestinal fungal dysbiosis could potentially contribute to the development and persistence of chronic IBD, highlighting the importance of investigating alternative therapeutic strategies able to attenuate fungal dysbiosis in the context of intestinal inflammation. In this study, we demonstrate that a combination of a recombinant protein (GILZp) and a compound with prebiotic properties could represent a new therapeutic strategy for the treatment of IBD, as it not only decreases inflammation and restores the integrity of the epithelial barrier, but reduces fungal dysbiosis associated with DSS-induced colitis.

microbiology↗